NCT05839210Recruiting
Lifestyle Intervention of Food and Exercise for Lymphoma Survivors
Lifestyle Intervention of Food and Exercise for Lymphoma Survivors (LIFE - L)
Source: ClinicalTrials.gov · Last updated 30 Jan 2026
Brief summary (registry, in English)
The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment completion and reduce treatment-related side effects.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- First submitted
- 31 Mar 2023
- Start date
- 26 Apr 2023
- Primary completion date
- 31 Oct 2026
- Lead sponsor
- University of Miami
- Diseases
- Hodgkin lymphoma
- NCT number
- NCT05839210
What you commit to
- Study type: Interventional
- Planned participants: 140
- From 26 Apr 2023 to the primary completion date, 31 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently following a vegan or ketogenic diet, or consuming more than 5 servings of fruit and vegetables per day for the prior month
- Engaging in \>150 minutes of moderate to vigorous physical activity on average per week for the prior month
Other illness
- History of dementia or major psychiatric disease
- History of recent (≤1 yr) stroke, myocardial infarction or congestive heart failure
Age
- Individuals younger than 18 years of age
Other
- Unable to provide consent
- Unable to read or understand English or Spanish
- Any contraindication for diet change or exercising as determined by physician
Who the study is looking for
- 18 years of age or older
- Any sex/gender
- Able to provide consent
- Able to read or understand English or Spanish
- Diagnosis of untreated Non-Hodgkin or Hodgkin lymphoma, requiring at least 6 cycles of chemotherapy, being treated with one of the following therapies at discretion of PIs:
- R-CHOP or R-CHOP-like regimen
- BR
- BV-AVD or ABVD or checkpoint inhibitor+AVD
- ECOG Performance Status grade of \<2
- PI approval needed if ECOG = 2
- Approval from treating oncologist, confirmed via email or in writing
- Delivery of chemotherapy treatments at one of the following institutions:
- Sylvester Comprehensive Cancer Center (including satellite/network sites)
- University of Miami Hospital/UHealth Tower
- Internet access on a smart phone, tablet, or computer
- Willing to be randomized to a Mediterranean diet/home-based physical activity intervention or waitlist-control group.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.